Jennifer Burstein, Vice President of Finance at Loxo Oncology, Inc. (LOXO), sold 3,300 shares at $89.50 ($294K) on 2017-09-18, disclosed to the SEC on 2017-09-20.
Open-market sale of $294k LOXO by Vice President of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.35 | 643 | $57K | 19.3% |
| 2 | $88.35 | 643 | $57K | 19.3% |
| 3 | $89.50 | 957 | $86K | 29.1% |
| 4 | $89.50 | 957 | $86K | 29.1% |
| 5 | $90.11 | 100 | $9K | 3.1% |
| Total | $89.07 avg | 3,300 |
| $294K |
| 100% |
| Filing → |
| LOXO | SELL | 2018-10-05 | $742K | — | Filing → |
| LOXO | SELL | 2018-09-14 | $667K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |